{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T21:05:31Z","timestamp":1780952731371,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T00:00:00Z","timestamp":1574035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T00:00:00Z","timestamp":1574035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Re-resection for incidental gallbladder cancer (iGBC) is associated with improved survival but little is known about residual disease (RD) and prognostic factors. In this study, survival after re-resection, RD, and prognostic factors are analyzed.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Patients with iGBC were identified from the Netherlands Cancer Registry, and pathology reports of re-resected patients were reviewed. Survival and prognostic factors were analyzed.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Overall, 463 patients were included; 24% (<jats:italic>n<\/jats:italic>\u2009=\u2009110) underwent re-resection after a median interval of 66\u00a0days. RD was present in 35% of patients and was most frequently found in the lymph nodes (23%). R0 resection was achieved in 93 patients (92%). Median overall survival (OS) of patients without re-resection was 13.7 (95% confidence interval [CI] 11.6\u201315.6), compared with 52.6\u00a0months (95% CI 36.3\u201368.8) in re-resected patients (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). After re-resection, median OS was superior in patients without RD versus patients with RD (not reached vs. 23.1\u00a0months; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). In patients who underwent re-resection, RD in the liver (hazard ratio [HR] 5.54; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and lymph nodes (HR 2.35; <jats:italic>p<\/jats:italic>\u2009=\u20090.005) were the only significant prognostic factors in multivariable analysis. Predictive factors for the presence of RD were pT3 stage (HR 25.3; <jats:italic>p<\/jats:italic>\u2009=\u20090.003) and pN1 stage (HR 23.0; <jats:italic>p<\/jats:italic>\u2009=\u20090.022).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Re-resection for iGBC is associated with improved survival but remains infrequently used and is often performed after the optimal timing interval. RD is the only significant prognostic factor for survival after re-resection and can be predicted by pT and pN stages.<\/jats:p>\n<\/jats:sec>","DOI":"10.1245\/s10434-019-08074-4","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T18:03:42Z","timestamp":1574100222000},"page":"1132-1142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Re-resection in Incidental Gallbladder Cancer: Survival and the Incidence of Residual Disease"],"prefix":"10.1245","volume":"27","author":[{"given":"Elise A. J.","family":"de Savornin Lohman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia G.","family":"van der Geest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa J. J.","family":"de Bitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris D.","family":"Nagtegaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis J. H. M.","family":"van Laarhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"van den Boezem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chella S.","family":"van der Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R.","family":"de Reuver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,18]]},"reference":[{"key":"8074_CR1","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/jso.24546","volume":"115","author":"C Are","year":"2017","unstructured":"Are C, Ahmad H, Ravipati A, et al. Global epidemiological trends and variations in the burden of gallbladder cancer. J Surg Oncol. 2017;115:580\u201390.","journal-title":"J Surg Oncol"},{"key":"8074_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jamcollsurg.2010.09.009","volume":"212","author":"JM Butte","year":"2011","unstructured":"Butte JM, Matsuo K, Gonen M, et al. Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. J Am Coll Surg. 2011;212:50\u201361.","journal-title":"J Am Coll Surg"},{"key":"8074_CR3","doi-asserted-by":"publisher","first-page":"1532835","DOI":"10.1155\/2017\/1532835","volume":"2017","author":"CSM Lau","year":"2017","unstructured":"Lau CSM, Zywot A, Mahendraraj K, Chamberlain RS. Gallbladder carcinoma in the United States: a population based clinical outcomes study involving 22,343 patients from the surveillance, epidemiology, and end result database (1973\u20132013). HPB Surg. 2017;2017:1532835.","journal-title":"HPB Surg"},{"key":"8074_CR4","first-page":"99","volume":"6","author":"R Hundal","year":"2014","unstructured":"Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99\u2013109.","journal-title":"Clin Epidemiol"},{"key":"8074_CR5","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/ijc.21683","volume":"118","author":"G Randi","year":"2006","unstructured":"Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118:1591\u2013602.","journal-title":"Int J Cancer"},{"key":"8074_CR6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s00268-018-4762-z","volume":"43","author":"L Gil","year":"2019","unstructured":"Gil L, de Aretxabala X, Lendoire J, et al. Incidental gallbladder cancer: how residual disease affects outcome in two referral HPB centers from South America. World J Surg. 2019;43:214\u201320.","journal-title":"World J Surg"},{"key":"8074_CR7","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.3748\/wjg.v18.i30.4019","volume":"18","author":"A Cavallaro","year":"2012","unstructured":"Cavallaro A, Piccolo G, Panebianco V, et al. Incidental gallbladder cancer during laparoscopic cholecystectomy: managing an unexpected finding. World J Gastroenterol. 2012;18:4019\u201327.","journal-title":"World J Gastroenterol"},{"key":"8074_CR8","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.2147\/OTT.S106580","volume":"9","author":"T Dorobisz","year":"2016","unstructured":"Dorobisz T, Dorobisz K, Chabowski M, et al. Incidental gallbladder cancer after cholecystectomy: 1990 to 2014. Onco Targets Ther. 2016;9:4913\u20136.","journal-title":"Onco Targets Ther"},{"key":"8074_CR9","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1007\/s00268-017-4215-0","volume":"42","author":"L Lundgren","year":"2018","unstructured":"Lundgren L, Muszynska C, Ros A, et al. Are incidental gallbladder cancers missed with a selective approach of gallbladder histology at cholecystectomy? World J Surg. 2018;42:1092\u20139.","journal-title":"World J Surg"},{"key":"8074_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/bjs.11035","volume":"106","author":"K Soreide","year":"2019","unstructured":"Soreide K, Guest RV, Harrison EM, et al. Systematic review of management of incidental gallbladder cancer after cholecystectomy. Br J Surg. 2019;106:32\u201345.","journal-title":"Br J Surg"},{"key":"8074_CR11","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/jso.20536","volume":"93","author":"R Steinert","year":"2006","unstructured":"Steinert R, Nestler G, Sagynaliev E, et al. Laparoscopic cholecystectomy and gallbladder cancer. J Surg Oncol. 2006;93:682\u20139.","journal-title":"J Surg Oncol"},{"key":"8074_CR12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/000313481708300721","volume":"83","author":"CG Ethun","year":"2017","unstructured":"Ethun CG, Le N, Lopez-Aguiar AG, et al. Pathologic and prognostic implications of incidental versus nonincidental gallbladder cancer: a 10-institution study from the United States extrahepatic biliary malignancy consortium. Am Surg. 2017;83:679\u201386.","journal-title":"Am Surg"},{"key":"8074_CR13","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/hpb.12444","volume":"17","author":"TA Aloia","year":"2015","unstructured":"Aloia TA, Jarufe N, Javle M, et al. Gallbladder cancer: expert consensus statement. HPB (Oxford). 2015;17:681\u201390.","journal-title":"HPB (Oxford)"},{"key":"8074_CR14","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1007\/s11605-007-0309-6","volume":"11","author":"TM Pawlik","year":"2007","unstructured":"Pawlik TM, Gleisner AL, Vigano L, et al. Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection. J Gastrointest Surg. 2007;11:1478\u201386. (Discussion 1486-7).","journal-title":"J Gastrointest Surg"},{"key":"8074_CR15","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jamcollsurg.2014.01.069","volume":"219","author":"JM Butte","year":"2014","unstructured":"Butte JM, Kingham TP, Gonen M, et al. Residual disease predicts outcomes after definitive resection for incidental gallbladder cancer. J Am Coll Surg. 2014;219:416\u201329.","journal-title":"J Am Coll Surg"},{"key":"8074_CR16","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s00268-011-1134-3","volume":"35","author":"D Fuks","year":"2011","unstructured":"Fuks D, Regimbeau JM, Le Treut YP, et al. Incidental gallbladder cancer by the AFC-GBC-2009 Study Group. World J Surg. 2011;35:1887\u201397.","journal-title":"World J Surg"},{"key":"8074_CR17","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453\u20137.","journal-title":"Lancet"},{"key":"8074_CR18","unstructured":"Edge SB, American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging handbook: from the AJCC cancer staging manual. New York: Springer; 2010."},{"key":"8074_CR19","first-page":"19","volume":"29","author":"M Casparie","year":"2007","unstructured":"Casparie M, Tiebosch AT, Burger G, et al. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol. 2007;29:19\u201324.","journal-title":"Cell Oncol"},{"key":"8074_CR20","volume-title":"Multiple imputation for nonresponse in surveys","author":"DB Rubin","year":"2004","unstructured":"Rubin DB. Multiple imputation for nonresponse in surveys. New York: Wiley; 2004."},{"key":"8074_CR21","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1365-2796.2010.02274.x","volume":"268","author":"A Mackinnon","year":"2010","unstructured":"Mackinnon A. The use and reporting of multiple imputation in medical research: a review. J Intern Med. 2010;268:586\u201393.","journal-title":"J Intern Med"},{"key":"8074_CR22","first-page":"545","volume":"158","author":"Y Shirai","year":"1992","unstructured":"Shirai Y, Yoshida K, Tsukada K, Muto T, Watanabe H. Early carcinoma of the gallbladder. Eur J Surg. 1992;158:545\u20138.","journal-title":"Eur J Surg"},{"key":"8074_CR23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1046\/j.1365-2168.2001.01749.x","volume":"88","author":"T Wakai","year":"2001","unstructured":"Wakai T, Shirai Y, Yokoyama N, et al. Early gallbladder carcinoma does not warrant radical resection. Br J Surg. 2001;88:675\u20138.","journal-title":"Br J Surg"},{"issue":"9","key":"8074_CR24","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/bjs.11205","volume":"106","author":"L Lundgren","year":"2019","unstructured":"Lundgren L, Muszynska C, Ros A, et al. Management of incidental gallbladder cancer in a national cohort. Br J Surg. 2019;106(9):1216\u201327.","journal-title":"Br J Surg"},{"key":"8074_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1477-2574.2012.00559.x","volume":"15","author":"DM Hari","year":"2013","unstructured":"Hari DM, Howard JH, Leung AM, et al. A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate? HPB (Oxford). 2013;15:40\u20138.","journal-title":"HPB (Oxford)"},{"key":"8074_CR26","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/j.1477-2574.2009.00108.x","volume":"11","author":"MA Abramson","year":"2009","unstructured":"Abramson MA, Pandharipande P, Ruan D, Gold JS, Whang EE. Radical resection for T1b gallbladder cancer: a decision analysis. HPB (Oxford). 2009;11:656\u201363.","journal-title":"HPB (Oxford)"},{"key":"8074_CR27","unstructured":"Landelijke Werkgroep Gastro-intestinale tumoren (2013). Galweg-en galblaascarcinoom. Retrieved from https:\/\/www.oncoline.nl\/galweg-en-galblaascarcinoom."},{"key":"8074_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1001\/jamasurg.2016.3642","volume":"152","author":"CG Ethun","year":"2017","unstructured":"Ethun CG, Postlewait LM, Le N, et al. Association of optimal time interval to re-resection for incidental gallbladder cancer with overall survival: a multi-institution analysis from the US extrahepatic biliary malignancy consortium. JAMA Surg. 2017;152:143\u20139.","journal-title":"JAMA Surg"},{"key":"8074_CR29","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1007\/s11605-017-3436-8","volume":"21","author":"JM Creasy","year":"2017","unstructured":"Creasy JM, Goldman DA, Gonen M, et al. Predicting residual disease in incidental gallbladder cancer: risk stratification for modified treatment strategies. J Gastrointest Surg. 2017;21:1254\u201361.","journal-title":"J Gastrointest Surg"},{"key":"8074_CR30","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1245\/s10434-016-5637-x","volume":"24","author":"CG Ethun","year":"2017","unstructured":"Ethun CG, Postlewait LM, Le N, et al. A novel pathology-based preoperative risk score to predict locoregional residual and distant disease and survival for incidental gallbladder cancer: a 10-institution study from the U.S. extrahepatic biliary malignancy consortium. Ann Surg Oncol. 2017;24:1343\u201350.","journal-title":"Ann Surg Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-08074-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-019-08074-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-08074-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:20:34Z","timestamp":1605572434000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-019-08074-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,18]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["8074"],"URL":"https:\/\/doi.org\/10.1245\/s10434-019-08074-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,18]]},"assertion":[{"value":"23 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}